Healthcare & Life Sciences
Melodia Therapeutics
Switzerlandwww.melodiatx.com/
Melodia Therapeutics is a Healthcare & Life Sciences startup based in Switzerland, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Melodia Therapeutics
Based in Switzerland, Melodia Therapeutics is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Melodia Therapeutics develops a next-generation DPP1 inhibitor using a selective non-covalent nitrile-based mechanism to treat severe neutrophil-driven inflammatory diseases affecting respiratory, dermatologic, and systemic disorders.
Explore Melodia Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.